Insights

Nine European companies and research institutes combine forces in the NanoPilot-project to create a pilot plant aimed at accelerating the development of nanomedicine by facilitating the production of small clinical batches under Good Manufacturing Practice (GMP). One of the first three nanopharmaceuticals chosen for production in the pilot plant is a promising intranasal HIV vaccine.

EuroNanoForum 2015 takes place on 10-12th June 2015 in Riga, Latvia, under the auspices of the Latvian presidency of the European Union. It is organised by the University of Latvia and Spinverse in cooperation with the European Commission’s Directorate-General for Research and Innovation and has received funding from the European Union’s Horizon 2020 research and innovation programme.

Over 60 experts from industry met the European Commission and research representatives to share experiences about nano-enabled innovations, future markets, framework and investment needs.

The VALUE4NANO project started in September 2013 and aims at developing an implementation roadmap of 4 value chains and their target products. The roadmap will include business modelling and planning for a set of pilot lines and it will involve strategic industry and European stakeholders from research and innovation. The selected areas are:

Rules of Innovation Will Change in Moscow in October

The Edge, real name David Howell Evans, known as the U2 guitarist, was one of the highlights at EuroNanoForum 2013. Instead of great guitar solos, he encouraged the global research and industry community to continue living dreams and reaching for the future: to continue the safe commercialisation of nanotechnology for improving people’s lives. His video greeting was in line with his activities in supporting public philanthropy and more specifically the fight against the cancer disease in the world.